#$PRLD
centrodiapophyseal fossa, podl postzygodiapophyseal lamina, posdf postzygapophyseal spinodiapophyseal fossa, poz postzygapophysis, pped pubic peduncle, prep preacetabular process, prld prezygodiapophyseal lamina, prpadf prezygapophyseal
November 13, 2026 at 12:27 AM
$PCVX-1 $XLY-1 $DGXX-1 $RSP-1 $PEP-1 $WMT-1 $CVNA-1 $KRE-1 $RKLB-1 $GEN-1 $EBAY-1 $SBLK-1 $BYD-1 $LUNR-1 $ABSI-1 $BOIL-1 $DRAM-1 $CYPH-1 $CXW-1 $NEO-1 $ICLR-1 $AOS-1 $QLD-1 $VMRK-1 $TDOC-1 $IVW-1 $OSPN-1 $GLD-1 $PRLD-1 $AAT-1 $NNE-1 $RBLX-1 $VTI-1 $IOVA-1 $EWY-1 $BMGL-1 $NBIS-1 $ORCU-1 $AA-1
October 29, 2026 at 8:46 PM
Ja. Prld
October 14, 2026 at 10:14 PM
BUY $PRLD (PRLD.O) [StrategicCollaboration] Commercial Deal; Announced @ 11:01:00Z
October 13, 2026 at 11:01 AM
Oct. 13 is Metastatic Breast Cancer Awareness Day. Names to watch: BriaCell #$BCTX, Oncolytics #$ONCY, Enliven #$ELVN, Plus Therapeutics #$PSTV, Prelude #$PRLD. Clinical-stage, high risk.
prismmarketview.com/closing-the-...
October 12, 2026 at 3:15 PM
September 17, 2026 at 1:49 PM
BUY $PRLD (PRLD.O) [FDA] @ 11:01:00Z
September 10, 2026 at 11:01 AM
🟢 #$PRLD — Clinical Milestone
FDA IND Clearance - PRT13722 Phase 1 Study
FDA cleared the IND for PRT13722, a first-in-class oral KAT6A selective degrader, enabling a Phase 1 study in patients with HR+/HER2- breast cancer. Enrollment anticipated to begin in Q4 2…

https://biostock.app/symbols/PRLD
September 10, 2026 at 11:56 AM
🚨 $PRLD
On September 10, 2026, Prelude Therapeutics Incorporated issued a press release announcing that the U.S. Food and Drug Administration cleared the Company to proceed with a Phase 1 study under its Investigational New Drug Application for PRT13722, a KAT6A degrader, being developed for the ...
SEC Filing: PRLD
Click to view the official SEC document.
www.sec.gov
September 10, 2026 at 11:31 AM
RNA-seq of mechanically isolated Zbs: 960 enriched mRNAs, encoding the very organelles inside it, and Mass spec finds 585 Zb proteins: ribosomes, and the PrLD helicases DDX3X and DDX5.
August 31, 2026 at 9:15 AM
📊 Stock movers right now:

CRE: $3.91 (-33.7%)
BANL: $16.10 (+20.1%)
BAOS: $0.35 (-18.8%)
AKTX: $10.70 (+18.8%)
PRLD: $5.47 (-13.7%)

More: https://suggestionbox.live/planet-markets
August 31, 2026 at 7:00 AM
PUNPEE's DJ is very relaxing and fun, I love it
www.youtube.com/watch?v=PRld...
PUNPEE @ODDJOB inc 20th ANNIVERSARY EXHIBITION
YouTube video by Pizza planet
www.youtube.com
December 5, 2024 at 10:02 AM
$KO-1 $CELC-1 $DARE-1 $AMZN-1 $SLB-1 $NKE-1 $IVV-1 $EMAT-1 $STLN-1 $SHOP-1 $M-1 $WULF-1 $TSCO-1 $AIRJ-1 $GOOGL-1 $MCHP-1 $NBIS-1 $PANW-1 $AAPL-1 $RCAT-1 $CRDO-1 $KDP-1 $MP-1 $SMCX-1 $OMER-1 $IWF-1 $PRLD-1 $DIA-1 $BILI-1 $ALM-1 $FCX-1 $DHI-1 $MNST-1 $XLF-1
August 14, 2026 at 8:20 PM
#$PRLD stock rises after #$INCY discontinues INCB160058 to focus on next-gen JAK2V617F therapies, boosting its exclusive option deal. notreload.xyz/xy/prelude-s...
Prelude Shares Jump as Incyte Drops Rival JAK2 Drug
Prelude Therapeutics stock rises after Incyte discontinues INCB160058 to focus on next-gen JAK2V617F therapies, boosting its exclusive option deal.
notreload.xyz
July 28, 2026 at 5:05 PM
#$PRLD +9.85% [Prelude Therapeutics receives FDA clearance to begin testing PRT12396, a targeted therapy for myeloproliferative neoplasms affecting thousands of patients.] notreload.xyz/prelude-ther...
Prelude Therapeutics Gets FDA Green Light for Groundbreaking Blood Cancer Treatment
Prelude Therapeutics receives FDA clearance to begin testing PRT12396, a targeted therapy for myeloproliferative neoplasms affecting thousands of patients.
notreload.xyz
February 3, 2026 at 4:22 PM
$PRLD -60%, $INCY +1.45% [Prelude Therapeutics streamlines its oncology pipeline — prioritizing JAK2V617F and KAT6A programs, pausing SMARCA2, and securing major funding through an Incyte partnership.] notreload.xyz/prelude-ther...
Prelude Therapeutics Refocuses Strategy to Advance Key Cancer Programs
Prelude Therapeutics streamlines its oncology pipeline — prioritizing JAK2V617F and KAT6A programs, pausing SMARCA2, and securing major funding through an Incyte partnership.
notreload.xyz
November 4, 2025 at 4:30 PM
🚨 Institutions #optionsvolume surge detected!

AM Top Momentum Activity from 🔥 INSIDERFINANCE.COM 🔥
1. #HIVE 32.1x
2. #TE 5.7x
3. #ZETA 3.1x
4. #PRLD 2.5x
5. #RIG 2.3x

#OptionFlow #OptionsTrading #Trading
May 18, 2026 at 8:19 PM